Thus, one may expect that a deleterious variant in ERCC4 may cause diseases reported in patients with ERCC4 malfunction (i.e., Xeroderma Pigmentosum, Fanconi Anemia Complementation Group F, and Group Q). This evidence concerns the gene ERCC4 and xeroderma pigmentosum.